Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence
Katarzyna Korzeniowska, Jerzy Jankowski, Artur Cieślewicz, Anna Jabłecka Department of Clinical Pharmacology, Poznan University of Medical Sciences, Poznan 61-848, PolandCorrespondence: Artur CieślewiczDepartment of Clinical Pharmacology, Poznan University of Medical Sciences, Długa 1/2 Str., Poznan...
Enregistré dans:
Auteurs principaux: | Korzeniowska K, Jankowski J, Cieślewicz A, Jabłecka A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f80b7307cee940139e2c39ff4c6ac18d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cardiotoxicidad inducida por tratamientos oncológicos. Fundamentos para la implementación de equipos de Cardio-Oncología
par: Hameau,René, et autres
Publié: (2018) -
European journal of heart failure. journal of the Working Group on Heart Failure of the European Society of Cardiology.
Publié: (2002) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
par: Sousa,MG, et autres
Publié: (2014) -
European journal of heart failure
Publié: (1999) -
Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
par: Amy Hyein Kim, et autres
Publié: (2022)